Nigeria, Sept. 7 -- The Prostate Cancer Transatlantic Consortium (CAPTC) has called for more investment in early detection, Africa-based clinical trials and survivor support as the burden of prostate cancer continues to rise across the continent.

Researchers, clinicians and survivors under the CAPTC network raised these concerns on Friday in Lagos at the consortium's 20th anniversary.

Despite two decades of global collaboration, CAPTC noted that African men remain disproportionately affected by prostate cancer, describing it as a "silent killer" that devastates families when detected late.

In her remarks, a haematology and oncology expert at the Mayo Clinic, Folakemi Odedina, a professor, said African men are still far more likely to b...